Ads
related to: fda, pharmaceuticals
Search results
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 3 days agoThe treatment, developed by Lykos Therapeutics, is a pharmaceutical version of midomafetamine,...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 3 days agoShe also helped shatter public trust in pharmaceutical companies, and played a leading role in a...
Jazz Pharmaceuticals stock maintains Outperform rating By Investing.com
Investing.com· 1 day agoOn Thursday, RBC (TSX:RY) Capital Markets sustained its Outperform rating and $176.00 price target...
MDMA-Maker Failed Its FDA Hearing — And Its PTSD Patients
Bloomberg· 2 days agoLykos Therapeutics showed up to a regulatory hearing woefully unprepared. Lisa Jarvis is a Bloomberg...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe two companies will pursue neuroplastogens – agents that induce rapid and long-lasting...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC Universal via AOL· 3 days agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA,...
MDMA Treatment for PTSD Gets Voted Against by FDA Advisers
TMZ· 3 days agoIn a 10-1 vote -- with the one person voting for MDMA's use -- the recommendation fell flat ......
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 4 days agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions | JD Supra
JD Supra· 15 hours agoIn Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. 2023-1952 (Fed. Cir. April 11, 2024), this case involves appellate review of a district ...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga via Yahoo Finance· 2 days agoWednesday, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) announced that the first patient had been dosed...